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High-ﬂow oxygen reduces 90-day mortality, compared with standard oxygen
or non-invasive ventilation, in patients with acute hypoxaemic respiratory
failureSynopsisSummary of: Frat JP, Thille AW, Mercat A, Girault C, Ragot S,
Perbet S, et al. High-ﬂow oxygen through nasal cannula in acute
hypoxemic respiratory failure. NEJM. 2015;372:2185- [3_TD$DIFF]2196.
Question: In patients who have acute hypoxaemic, non-
hypercapnic respiratory failure, does high-ﬂow oxygen reduce
intubation rates or 90-day mortality compared with non-invasive
ventilation or standard oxygen? Design:Multicentre, randomised,
controlled trial with concealed allocation. Participants, therapists
and outcome assessors were not blinded, although intubation
criteria were determined a priori to minimise bias. Setting:
Twenty-three intensive care units in France and Belgium. Exclusion
criteria included: exacerbation of asthma/chronic respiratory
failure, cardiogenic pulmonary oedema, haemodynamic instability/
vasopressors, Glasgow Coma Scale  12 points, contraindications
to non-invasive ventilation and urgent need for endotracheal
intubation. Randomisation of 313 participants allocated 106 to
high-ﬂow oxygen, 111 to non-invasive ventilation and 96 to
standard oxygen. Interventions: The high-ﬂow oxygen group
received continuous oxygen therapy through large-bore binasal
prongs at 50 l/min. Fraction of inspired oxygen was initiated
at 1.0 and adjusted to maintain arterial oxygen saturation  92%
(for 2 days). The non-invasive ventilation group received pressure
support through a facemask, adjusted to achieve an expired tidal
volume of 7 to 10 ml/kg, with initial positive end-expiratory
pressure of 2 to 10 cmH2O (for  8 hours/day for  2 days;
parameters were adjusted to maintain arterial oxygen saturation
 92%). The standard oxygen group received continuous oxygen
through a non-[4_TD$DIFF]rebreather facemask at  10 l/min (rate adjusted1836-9553/ 2015 Australian Physiotherapy Association. Published by Elsevier B.V. Alto maintain arterial oxygen saturation  92%). Outcome measures:
The primary outcome was the proportion of participants that was
intubated at day 28 (using pre-speciﬁed criteria for intubation).
Secondary outcomes included all-cause mortality (in intensive care
and at 90 days) and ventilator-free days at day 28.Results:A total of
310 participants were analysed. There were no differences in
intubation rates between standard oxygen and high-ﬂow oxygen
(OR1.45, 95%CI0.83 to2.55), andnon-invasiveventilationandhigh-
ﬂowoxygen (OR1.65, 95%CI 0.96 to 2.84). Ventilator-free dayswere
higher following high-ﬂow oxygen compared with non-invasive
ventilation (mean difference –[5_TD$DIFF] .0 days, 95% CI –7.8 to –2.3[1_TD$DIFF]) but not
standard oxygen (mean difference –[6_TD$DIFF]2.0 days, 95% CI –4.5 to 0.5[1_TD$DIFF]).
Mortality at 90 days was better following high-ﬂow oxygen
compared with both standard oxygen (hazard ratio [HR] 2.01,
95% CI 1.01 to 3.99) and non-invasive ventilation (HR 2.50, 95% CI
1.31 to 4.78). Conclusion: Although treatment with high-ﬂow
oxygen, non-invasive ventilation or standard oxygen did not result
in different intubation rates, thosewhowere treatedwith high-ﬂow
oxygen had better 90-day mortality.
[Mean differences and 95% [7_TD$DIFF]CIs for ventilator-free days
calculated by the CAP Editor]
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http://dx.doi.org/10.1016/j.jphys.2015.07.002CommentaryNon-invasive ventilation is highly effective in reducing
intubation and mortality rates in patients with acute hypercapnic
respiratory failure.1 However, evidence of beneﬁt in acute
hypoxaemic respiratory failure is less convincing.2 Additionally,
non-invasive ventilation requires skill to implement and optimise.
High-ﬂow oxygen is increasingly being used as an alternative to
non-invasive ventilation in managing acute hypoxaemia. This
technique is simple to set up and permits amore precise and higher
delivery of inspired oxygen than standard oxygen delivery devices.
The high gas ﬂow rates that are used also generate low level
positive end-expiratory airway pressure, providing physiological
beneﬁts including reduced work of breathing, improved ventila-
tion-perfusion matching and increased washout of carbon dioxide
in the anatomical dead space. However, whether these beneﬁts
extend to improvements in important patient outcomes such as
intubation and mortality rates has not previously been studied,
despite increasing acceptance as usual care in acute care settings.
While the study of Frat et al[2_TD$DIFF] is a negative trial with respect to the
primary outcome of intubation rate, it provides useful insights into
the use of high-ﬂow oxygen and non-invasive ventilation in acute
hypoxaemic respiratory failure. Since neither high-ﬂow oxygen nor
non-invasive ventilation reduced intubation rates, closemonitoring
is crucial and intubation is necessary if rapid clinical improvementsare not achieved, as delaying escalation of therapy is associatedwith
poorer outcome.3 The reduced intubation rates amongst those with
more severe hypoxaemia allocated to high-ﬂow oxygen is interest-
ing and warrants further investigation. Comfort and reductions in
dyspnoea were greater with high-ﬂow oxygen, suggesting that this
therapy is abetter choice thannon-invasiveventilation forpalliation
of patients with end-stage respiratory failure.
Before the widespread adoption of this technique in respiratory
and acute care settings, furtherwell-designed trials such as this are
crucial to better deﬁne the timing, indications and limitations of
high-ﬂow oxygen in respiratory and critical care practice.
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